Members get an extra 10% shares in addition to rewards below!
Get rewarded for investing more into Prisma Imaging:
OVERVIEW
A recent study conducted by the American Horse Council Foundation (source) revealed that the economic activity involved in caring for the nation's 7.2 million horses directly contributes over $122 billion to America's Gross Domestic Product and 1.7 million jobs. The US horse population of 7.2 million is a fraction of the worldwide equine population which totals a staggering 50 million horses.
However, to be successful, horses need to be healthy.
THE EQUINE PATIENT NEEDS PRECISE MEDICAL IMAGING
According to our research, horses are prey animals, which means that instinctively they will hide any signs of injury or distress to avoid being the next meal for a predator that looks for the weak to make an easy kill. Unlike Mr. Ed, our 4-legged friends can’t tell us when they’re hurt, and most catastrophic, fatal occurrences are caused by latent injuries or defects in the skeletal system that go undetected. So, an efficient, effective way to discover these problems will reduce these tragedies and help save lives.
THE PROBLEM
Current imaging technology has several limitations and is not well-suited for horses. It requires the patient to be anesthetized which is dangerous and potentially life-threatening for the horse and unsafe for medical personnel (source). It also necessitates a team to awkwardly position an unconscious twelve-hundred-pound patient into a CT donut. Lastly, it can’t image the high-mass parts of the equine anatomy which often leads to an incomplete or faulty diagnosis.
Issues with this current imaging technology:
THE SOLUTION
* Prisma Imaging products shown in the above video are in the prototype phase. Product is not currently available on the market.
Prisma’s technology will be easy to implement and safe for both the horse and handler. The horse is walked into position and requires only mild sedation; Robotics provides unlimited access to virtually every anatomical region of a standing, conscious horse including the axial skeleton, hips, pelvis, and abdomen. Prisma’s system utilizes two types of radiographic imaging technologies which reveal the high-mass areas of the equine anatomy and generates high-resolution images that current imaging technology can’t do. The horse is safely in and out fast.
WHY WE ARE DIFFERENT THAN OTHERS IN THE CURRENT COMPETITIVE LANDSCAPE
We believe that none of the attempts to build equine CT systems offer a comprehensive solution to image the entire anatomy. Or worse, they make anesthesia necessary which is potentially dangerous and life-threatening for the patient. According to insights from our research, systems 1 and 2 are essentially repurposed CT equipment from the human market and are considerably more expensive compared to the Prisma system. System 4 had the right idea in using robots, but they never developed a working system and has been out of business since 2016. System 5, which also uses robots, has yet to produce diagnostic quality CT images and can’t image the high-mass parts of the horse, which is a shortcoming of System 3 as well. We believe Prisma offers superior capabilities and other innovations, which you’ll see later, between current radiographic imaging technology and these ventures.
THE SAFETY OF THE HORSE AND THE HANDLER ARE PARAMOUNT
According to our research, Prisma is one of the only standing CT systems that employs advanced design to ensure that the horse and the handler are safe during the imaging process.
*The above is a rendering of a future product. Images are computer generated demo versions. Product is still currently under development not yet available on the market.
*The above is a rendering of a future product. Images are computer generated demo versions. Product is still currently under development not yet available on the market.
THE MARKET
Source: Jockey Club
The obvious beneficiaries of Prisma’s imaging technology will be horses that are in the competitive sectors. According to our research, in looking at these categories in the US, racing and showing, a consensus among trainers, horse owners and vets revealed that a horse that is active in the racing sector should be proactively imaged a minimum of 4 times a year. The company believes that, in the US, approximately 200,000 out of the 1.2 million horses in the racing category are actively involved in training and competition. The determination of the appropriate number of scans was based on a horse’s race schedule, training regimen and medical history. Also taken into consideration was the advanced, safe and efficient functionality of Prisma’s system, especially since the horse does not need to be anesthetized, and our ability to image the axial skeleton. At $1,000/study, this equates to a TAM of $800 million for the racing category.
Based on discussions we've had with trainers, owners and vets, the company believes that for the showing category active participants, which in the US is approximately 600,000 out of the 1.2 million population, the consensus was that they should be proactively imaged a minimum of once a year. The determination for the frequency was arrived at with a similar methodology as racing. At $1,000/study, this equates to a TAM of $600 million for the showing category. Looking at the remaining 3.1 million recreational horses in the US, the worldwide equine population of 50 million and based on a consensus from medical professionals, we may conclude that there is a multi-billion- dollar market opportunity for Prisma’s imaging technology.
OUR TRACTION
Since its inception, Prisma has been in regular contact with a number of research universities, large equine veterinary practices and major equine industry organizations, all of which are very supportive and enthusiastic about the technology we are developing and the benefits that it will provide to the equine industry. We have strong levels of interest from these parties and they are excited to see the commercialization of our technology
A functional working prototype system exists and the first “field-ready” system is being installed at an equine veterinary practice in July. We hope to begin commercial sales in early 2023.
As we move toward commercialization, Prisma’s business model will be based on a three-segment sale strategy for the equine market:
MARKET EXPANSION OPPORTUNITIES
Technical advancements from initially operating within the equine industry will create opportunities to develop other potential applications. For example, other large animals in zoos and nature preserves, the cattle and food animal industry, and even in the human market to address the imaging challenges for the growing bariatric population.
Other potential opportunities will come from newly available data about the equine patient’s axial skeleton made possible by Prisma’s technology that will be accumulated from the system’s utilization. This valuable data will be correlated to the horses’ performance during their competitive career. Eventually, the aggregated results could be used as a predictor of a horses’ performance potential and other important characteristics that will benefit the industry.
WHY INVEST
Prisma Imaging offers investors the opportunity to be part of one of the next disruptors in promoting better care and safer, more humane existence for our beloved horses.
Additionally, Kirenaga Partners has institutionally vetted us and has been taking the lead investment in Prisma’s current seed round, which is a great vote of confidence in the technology that Prisma has developed. This is further amplified by also having the financial support of Triple Ring Technologies, Prisma’s technical lead and co-development partner, as they are experienced in the imaging industry.
*The above is a rendering of a future product. Images are computer generated demo versions. Product is still currently under development not yet available on the market.
In the future, we envision our ground-breaking, highly beneficial diagnostic technology supporting the sustainable, humane treatment of animals in all categories, including our beloved pets, animals that live in captivity (in zoos and nature habitats), and in our food chain.
Prisma is on the precipice of becoming the next disruptor in equine diagnostics, paving the way for a healthier, safer, more humane quality of life for our beloved horses.
Prisma is redefining equine diagnostics and preventative care with its robotically-controlled system which is capable of capturing high-quality CT and radiographic images of a horse's entire anatomy while they are conscious, standing and safe.
Prisma Imaging has successfully developed a new system for equine diagnostic imaging that addresses the shortcomings of current technology. Founded in 2016, Prisma developed a system that captures CT and radiographic images of the entire anatomy of a standing, weight-bearing and conscious horse.
Prisma Imaging has successfully developed a new system for equine diagnostic imaging that addresses the shortcomings of current technology. Founded in 2016, Prisma developed a system that captures CT and radiographic images of the entire anatomy of a standing, conscious horse.
The advanced imaging capabilities established through Prisma’s research and development is different from anything available in the marketplace. The resulting system represents a game-changer for the overall effect on equine diagnostics and horse health care.
Prisma Founder and CEO Michael Silver was a guest on The Horse Talk Show on September 23. He discussed how the Prisma system is a game-changer in horse health care solving the shortcomings in current equine imaging technology.
Prisma has come to mutually agreeable terms with B.W. Furlong & Associates to be the recipient of Prisma's first robotic imaging system. This agreement represents a significant milestone that validates the equine veterinary community's demand for Prisma's novel technology.
Company | : | Prisma Imaging, Inc. |
Corporate Address | : | 13900 Tech City Circle, Suite #200, Alachua, FL 32615 |
Offering Minimum | : | $10,000.00 |
Offering Maximum | : | $1,070,000.00 |
Minimum Investment Amount(per investor) | : | $300.00 |
Offering Type | : | Equity |
Security Name | : | Non-Voting Common Stock |
Minimum Number of Shares Offered | : | 10,000 |
Maximum Number of Shares Offered | : | 1,070,000 |
Price per Share | : | $1.00 |
Pre-Money Valuation | : | $10,005,841 |
*Maximum Number of Shares Offered subject to adjustment for bonus shares. See Bonus info below.
Time-Based:
Friends and Family Early Birds
Invest within the first 48 hours and receive 20% bonus shares
Super Early Bird Bonus
Invest within the first week and receive 15% bonus shares
Early Bird Bonus
Invest within the first two weeks and receive 10% bonus shares
Amount-Based:
$5000+
Receive 5% Bonus Shares
$10,000+
Receive 10% Bonus Shares
$15,000+
Receive 15% Bonus Shares
$20,000+
Receive 20% Bonus Shares + Zoom call or in-person meeting with the founder
*All perks occur when the offering is completed.
The 10% StartEngine Owners' Bonus
Prisma Imaging will offer 10% additional bonus shares for all investments that are committed by investors that are eligible for the StartEngine Crowdfunding Inc. OWNer's bonus.
This means eligible StartEngine shareholders will receive a 10% bonus for any shares they purchase in this offering. For example, if you buy 100 shares of Common Stock at $1.00 / share, you will receive 110 shares of Common Stock, meaning you'll own 110 shares for $100. Fractional shares will not be distributed and share bonuses will be determined by rounding down to the nearest whole share.
This 10% Bonus is only valid during the investor's eligibility period. Investors eligible for this bonus will also have priority if they are on a waitlist to invest and the company surpasses its maximum funding goal. They will have the first opportunity to invest should room in the offering become available if prior investments are canceled or fail.
Investors will receive the highest single bonus they are eligible for among the bonuses based on the amount invested and time of offering elapsed (if any). Eligible investors will also receive the Owner’s Bonus in addition to the aforementioned bonus.
A crowdfunding investment involves risk. You should not invest any funds in this offering unless you can afford to lose your entire investment. In making an investment decision, investors must rely on their own examination of the issuer and the terms of the offering, including the merits and risks involved. These securities have not been recommended or approved by any federal or state securities commission or regulatory authority. Furthermore, these authorities have not passed upon the accuracy or adequacy of this document. The U.S. Securities and Exchange Commission does not pass upon the merits of any securities offered or the terms of the offering, nor does it pass upon the accuracy or completeness of any offering document or literature. These securities are offered under an exemption from registration; however, the U.S. Securities and Exchange Commission has not made an independent determination that these securities are exempt from registration.
We're excited to see our community come in and invest in Prisma Imaging!
Our Insiders have invested a total of $11,300 into the offering to date!
We hope you join in as well! Invest in Prisma Imaging
Please refer to the Company’s offering materials for further information and refer to the Company’s Risk Factors.
Prisma Founder and CEO Michael Silver was a guest on The Horse Talk Show. He discussed how the Prisma system is a game-changer in horse health care solving the shortcomings in current equine imaging technology.
The Horse Show Talk features all breeds, all disciplines, and lots of top equestrians. Live-stream horse broadcasts, with medical advice from some of the top veterinarians, interviews with the most well-known equestrians from all disciplines, ‘how-tos’ from equine experts, plus exciting interviews from events like the Kentucky Derby, Live Oak International, and more. For all things equine, listen to Louisa Barton and start living vicariously through a variety of thrilling horse adventures.
For more about the podcast visit TheHorseShowTalkNetwork.com.
Prisma is the next generation of equine imaging focused on the development of new imaging techniques capable of capturing the never-before-seen perspectives of the equine patient.
The revolutionary Prisma system captures high-quality equine radiography and CT images of the entire anatomy of a standing, weight-bearing, conscious horse allowing for a safer and more effective, and efficient diagnosis, prognosis, and overall improved horse health care.
For more information, contact Prisma.
Prisma was selected to be one of seventeen companies to present at the 2022 Emerging Tech Showcase, an event that features ventures that are developing new “cutting-edge technology.
“I was thrilled and honored to have Prisma be among this elite group of companies that represented some of the newest and most innovative technology that I have seen."
Michael Silver
Founder & CEO
{{ profileCtrl.commentsLoading ? 'Loading...' : 'Show More Comments' }}